Digital technologies are transforming the pharmaceutical industry's ability to meet the evolving needs of healthcare professionals (HCPs) and patients.
A new code of practice has been drawn up in the UK to try to make sure that research on human embryo models derived from stem cells is carried out ethically and responsibly.
Cell and gene therapies (CGT) offer immense potential for healthcare – opening up countless possibilities for saving and improving lives, which were previously unavailable through existing
The FDA has published draft guidance giving its position on the ethical reasons for including children in clinical trials, and protecting them from harm.
In a new white paper from the World Without Disease initiative, a 2024 update is provided of the current endeavours and developments that have occurred since inaugural discussions last year
